Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biology (Basel) ; 12(9)2023 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-37759616

RESUMO

We previously reported a novel secondary progressive multiple sclerosis (SPMS) model, progressive experimental autoimmune encephalomyelitis (pEAE), in oligodendroglia-specific Cx47-inducible conditional knockout (Cx47 icKO) mice. Based on our prior study showing the efficacy of iguratimod (IGU), an antirheumatic drug, for acute EAE treatment, we aimed to elucidate the effect of IGU on the SPMS animal model. We induced pEAE by immunizing Cx47 icKO mice with myelin oligodendrocyte glycoprotein peptide 35-55. IGU was orally administered from 17 to 50 days post-immunization. We also prepared a primary mixed glial cell culture and measured cytokine levels in the culture supernatant after stimulation with designated cytokines (IL-1α, C1q, TNF-α) and lipopolysaccharide. A migration assay was performed to evaluate the effect of IGU on the migration ability of T cells toward mixed glial cell cultures. IGU treatment ameliorated the clinical signs of pEAE, decreased the demyelinated area, and attenuated glial inflammation on immunohistochemical analysis. Additionally, IGU decreased the intrathecal IL-6 level and infiltrating Th17 cells. The migration assay revealed reduced Th17 cell migration and IL-6 levels in the culture supernatant after IGU treatment. Collectively, IGU successfully mitigated the clinical signs of pEAE by suppressing Th17 migration through inhibition of IL-6 production by proinflammatory-activated glial cells.

2.
Brain Nerve ; 75(6): 705-710, 2023 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-37287353

RESUMO

Neuromyelitis optica spectrum disorders (NMOSD) are inflammatory autoimmune disorders of the central nervous system, that primarily cause optic neuritis and myelitis. Aquaporin-4 (AQP4) antibody is the key in NMOSD pathophysiology, which causes astrocytopathy, demyelination, and neuropathy through complement activation and cell-mediated immunity. Currently, biopharmaceutical agents are introduced for preventing relapse with high efficacy, expected to reduce side effects derived from long-term steroid therapy, and improve patients' quality of life.


Assuntos
Mielite , Neuromielite Óptica , Humanos , Neuromielite Óptica/tratamento farmacológico , Aquaporina 4 , Qualidade de Vida , Sistema Nervoso Central , Autoanticorpos
3.
Front Aging Neurosci ; 15: 1117851, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36936499

RESUMO

Introduction: Cerebral small vessel disease (SVD) is one of the leading causes of stroke; each neuroimaging marker of SVD is correlated with vascular risk factors and associated with poor prognosis after stroke. However, longitudinal studies investigating the association between comprehensive SVD burden scoring system, "total SVD score" - which encompasses the established neuroimaging markers of lacunae, cerebral microbleeds (CMBs), white matter hyperintensities (WMH) including periventricular hyperintensities, and perivascular spaces in basal ganglia- and clinical outcomes are limited. The aim of this study is to determine the association between SVD burden and long-term prognosis in patients with ischemic stroke. Methods and design: This prospective, single-center, observational study enrolled patients with acute ischemic stroke, including cerebral infarction and transient ischemic attack. Magnetic resonance imaging scans were performed, and then total SVD score (range, 0-4) was calculated. We recorded baseline characteristics and evaluated the relationships of long-term outcomes to SVD neuroimaging markers and total SVD score. Stroke recurrence was thought as primary outcome. Hazard ratios (HRs) of events during follow-up were calculated using Cox proportional hazards modeling with adjustments for age, sex, hypertension, dyslipidemia, diabetes mellitus, atrial fibrillation, and smoking. Cumulative event rates were estimated using the Kaplan-Meier method. Results: Consecutive 564 acute ischemic stroke patients were enrolled according to inclusion and exclusion criteria. A total of 467 participants with first-ever ischemic stroke were analyzed (median age 75.0 [interquartile range, 64.0-83.0] years, 59.3% male). Total SVD score was 0 point in 47 individuals (12.0%), 1 point in 83 (21.2%), 2 points in 103 (26.3%), 3 points in 85 (21.7%), and 4 points in 73 (18.7%). Twenty-eight recurrent stroke events were identified during follow-up. Total SVD score ≥ 2, presence of CMBs, and moderate-to-severe WMH were associated with increased risk of recurrent stroke events (HR 9.31, 95% confidence interval [CI] 2.33-64.23; HR 2.81, 95% CI 1.08-7.30; HR 2.90, 95% CI 1.22-6.88, respectively). Conclusion: The accumulation of SVD biomarkers as determined by total SVD score offered a reliable predictor of stroke recurrence. This study established a firm understanding of SVD prognosis in clinical settings.

4.
Rinsho Shinkeigaku ; 62(1): 33-38, 2022 Jan 28.
Artigo em Japonês | MEDLINE | ID: mdl-34924471

RESUMO

A 54-year-old woman was diagnosed with acute adult T-cell leukemia (ATL) in November 2015 and underwent allogeneic hematopoietic stem cell transplantation in March 2016. Cognitive impairment appeared suddenly around May 2019, and MRI of the brain showed cerebral white matter lesions. Cerebrospinal fluid examination showed no significant findings other than elevated protein. Brain biopsy showed inflammatory cells, (mainly CD8-positive T lymphocytes), infiltrating the white matter. Based on the pathological findings and the history of chronic graft versus host disease (GVHD) in the lungs and intestines, we diagnosed central nervous system involvement of GVHD (CNS-GVHD). Immunotherapy with steroids and mycophenolate mofetil resulted in improvement of the cognitive dysfunction and inflammatory findings in the spinal fluid. This case is the first report of CNS-GVHD in ATL, suggesting the importance of diagnosis by brain biopsy and the efficacy of immunotherapy.


Assuntos
Doença Enxerto-Hospedeiro , Transplante de Células-Tronco Hematopoéticas , Leucemia-Linfoma de Células T do Adulto , Sistema Nervoso Central , Feminino , Doença Enxerto-Hospedeiro/etiologia , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Leucemia-Linfoma de Células T do Adulto/terapia , Pessoa de Meia-Idade , Transplante Homólogo
5.
Rinsho Shinkeigaku ; 61(5): 319-324, 2021 May 19.
Artigo em Japonês | MEDLINE | ID: mdl-33867416

RESUMO

A 61-year-old man was admitted to our hospital due to cerebral infarction in the pons and the right putamen. On admission (day 3 from symptom onset), laboratory testing showed a white blood cell count of 13,100/µl with hypereosinophilia of 3,734/µl. As deep vein thrombosis was detected on contrast-enhanced CT, we started anticoagulation therapy. There were no cardio-embolic sources, including right-to-left shunt, but eosinophil infiltration was found in biopsy specimens of the gastric mucosa. These findings allowed us to diagnose multiple perforator infarction due to idiopathic hypereosinophilic syndrome (idiopathic HES). After the administration of oral prednisolone was started on day 10, his hypereosinophilia rapidly improved, and no recurrence of deep perforator infarction occurred other than a symptomatic infarction in the left putamen at day 19. There are a few reports of idiopathic HES with multiple infarctions developing in deep perforator regions. The current case suggests that idiopathic HES could cause multiple cerebral infarction restricted to deep perforator areas.


Assuntos
Infarto Cerebral/etiologia , Síndrome Hipereosinofílica/complicações , Síndrome Hipereosinofílica/tratamento farmacológico , Administração Oral , Eosinófilos/patologia , Mucosa Gástrica/patologia , Humanos , Síndrome Hipereosinofílica/patologia , Masculino , Pessoa de Meia-Idade , Ponte/irrigação sanguínea , Prednisolona/administração & dosagem , Pulsoterapia , Putamen/irrigação sanguínea , Resultado do Tratamento , Trombose Venosa/etiologia
6.
Intern Med ; 58(13): 1935-1938, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-30799335

RESUMO

We herein report the case of a 38-year-old man who developed parkinsonism 4 years after ingesting glyphosate. The patient presented with right-sided bradykinesia and cogwheel rigidity without autonomic symptoms. Magnetic resonance imaging of the brain and [123I]-metaiodobenzylguanidine myocardial scintigraphy were normal. A drastic response to levodopa and the presence of levodopa-induced dyskinesia without strong non-motor symptoms were seen in this patient. We considered that young-onset atypical parkinsonism was associated with a history of sublethal glyphosate ingestion. Epidemiologic investigations have shown that exposure to pesticides is a risk factor for Parkinson's disease (PD). Our findings support the notion that glyphosate exposure might be related to the onset of PD.


Assuntos
Glicina/análogos & derivados , Herbicidas/toxicidade , Levodopa/uso terapêutico , Rigidez Muscular/induzido quimicamente , Doença de Parkinson/complicações , Doença de Parkinson/tratamento farmacológico , Adulto , Glicina/toxicidade , Humanos , Imageamento por Ressonância Magnética , Masculino , Doença de Parkinson/patologia , Resultado do Tratamento , Glifosato
7.
Chem Pharm Bull (Tokyo) ; 53(4): 431-4, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15802846

RESUMO

An attempt was made to produce carrier particles for dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed. The lactose carrier particles were coated with lactose aqueous solution containing hydroxypropyl methyl cellulose (HPMC) as a binder using a Wurster coating apparatus. Drug/carrier powder mixtures were prepared consisting of micronized salbutamol sulfate and lactose carriers under various particle surface conditions. These powder mixtures were aerosolized by a Jethaler((R)), and the in vitro deposition properties of salbutamol sulfate were evaluated by a twin impinger. The in vitro inhalation properties of the powder mixture prepared using the coated lactose carrier differed significantly compared with those of the powder mixture prepared using the uncoated lactose carrier, indicating improvements in in vitro inhalation properties of sulbutamol sulfate. In vitro inhalation properties increased with the surface coating time. This surface coating system would thus be valuable for increasing the in vitro inhalation properties of dry powder inhalation with lactose carrier particles.


Assuntos
Composição de Medicamentos/métodos , Pós , Administração por Inalação , Albuterol/administração & dosagem , Fenômenos Químicos , Físico-Química , Portadores de Fármacos , Lactose , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Solubilidade , Propriedades de Superfície
8.
Int J Pharm ; 290(1-2): 73-81, 2005 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-15664132

RESUMO

The present study examined the stability of a gene in powders prepared with supercritical carbon dioxide (CO(2)) from the viewpoints of the ternary structure of DNA and in vivo transfection potential. An aqueous chitosan-pCMV-Luc complex solution containing mannitol was injected into the stream of a supercritical CO(2)/ethanol admixture to precipitate a gene powder. The obtained gene powders and gene solutions were placed in stability chambers at 25 or 40 degrees C for 4 weeks. The integrity and transfection potency of the gene were examined by electrophoresis and in vivo pulmonary transfection study in mice. The supercritical CO(2) process decreased the supercoiled DNA during the manufacturing process; however, the decrease in the remaining supercoiled and open circular DNA in the powders during storage was much slower than that in solutions. In addition, the powders had higher transfection potency than the solutions containing the same amount of DNA. The effect of chitosan on the stability of DNA in solutions was not obvious in the solutions but it improved the stability of DNA in powders during manufacturing and storage. Thus, a gene powder with a cationic vector is a promising ready-to-use formulation for inhalation therapy of pulmonary diseases.


Assuntos
Dióxido de Carbono/química , Quitosana/síntese química , Cromatografia com Fluido Supercrítico/métodos , DNA/síntese química , Animais , Química Farmacêutica , Quitosana/análise , Cromatografia com Fluido Supercrítico/instrumentação , DNA/análise , DNA/genética , DNA Circular/análise , DNA Circular/síntese química , DNA Super-Helicoidal/análise , DNA Super-Helicoidal/síntese química , Estabilidade de Medicamentos , Feminino , Camundongos , Camundongos Endogâmicos ICR , Plasmídeos/análise , Plasmídeos/síntese química , Plasmídeos/genética , Pós
9.
Yakushigaku Zasshi ; 40(2): 137-46, 2005.
Artigo em Japonês | MEDLINE | ID: mdl-17152837

RESUMO

A chronological table of the main diseases that have appeared throughout Japanese history was prepared for pharmacy students, especially for students of clinical pharmacy in the new 6-year system. In ancient times (even in the 8th century), smallpox and measles prevailed in Japan. Japanese people prayed to gods and Buddha to cure the sick. New infectious diseases, like ruebella, pest, typhoid fever, dysentery, cholera, leprosy, etc., prevailed with the increasing exchange of culture from foreign countries. After the vaccines and the toxides were prepared, these infectious diseases were gradually stamped out in Japan early in the Meiji Era. While, public nuisances like the Minamata disease (CH3HgCl), Itaiitai disease (Cd), and atmospheric pollution with sulfurous acid gas, drug-induced suffering (Thalidomide, Sumon, AIDS, etc.) and toxin contaminations in foods have recently increased and produced new diseases. However, these diseases can be prevented if the workers in factories and government officers keep in mind the medical ethics and the ethics for pharmacists to protect the health of people from diseases. Today, cancer, diseases of cerebral vessels, heart diseases, and pneumonia are the four most important causes of death related to aging.


Assuntos
Doença , Educação em Farmácia , História Antiga , Cronologia como Assunto , Japão
10.
Chem Pharm Bull (Tokyo) ; 52(8): 938-42, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15304985

RESUMO

The effects of the surface processing of lactose carrier particles on the dry powder inhalation properties of salbutamol sulfate were investigated. Lactose carrier particles were processed using a high-speed elliptical-rotor-type powder mixer (Theta-Composer). In the present study, drug/carrier powder mixtures were prepared, consisting of micronized salbutamol sulfate and coarse lactose carriers with various particle surface conditions prepared by surface processing. These powder mixtures were aerosolized by a Jethaler, and the in vitro inhalation properties of salbutamol sulfate were evaluated with a twin impinger. Compared with those of the powder mixed with unprocessed lactose carriers, the in vitro inhalation properties of the powder mixture prepared using the surface processed lactose carriers were significantly different, showing that the in vitro inhalation properties of salbutamol sulfate were improved. The in vitro inhalation properties increased with the rotor rotation rate. Using this surface processing system would thus be valuable for increasing the inhalation properties of dry powder inhalation with lactose carrier particles.


Assuntos
Albuterol/química , Broncodilatadores/química , Lactose/química , Pós/química , Administração por Inalação , Albuterol/administração & dosagem , Broncodilatadores/administração & dosagem , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Lactose/administração & dosagem , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Propriedades de Superfície , Temperatura , Difração de Raios X
11.
Int J Pharm ; 271(1-2): 41-52, 2004 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-15129972

RESUMO

The effect of pulmonary absorption enhancers on the stability of active ingredients is an important factor for successful inhalation therapy as well as the effect on pharmacological activity and safety. We examined the effect of pulmonary absorption enhancers on the stability of insulin in dry powders prepared by a spray-drying technique. Although the hypoglycemic effect was greatly improved when a dry insulin powder containing citric acid (MIC SD) was administered, insulin in the MIC SD was unstable compared with the other powders examined. Bacitracin and Span 85, which are potent pulmonary absorption enhancers of insulin formulated in solutions, showed no deteriorative effect on the stability of dry insulin powder. However, they did not improve the hypoglycemic effect of insulin in dry powders. We modified the insulin dosage form with citric acid to improve the insulin stability at room temperature without loss of hypoglycemic activity. MIC Mix was formulated as a combination of insulin powder (MI') and citric acid powder (MC). MIC Mix showed hypoglycemic activity comparable to MIC SD while the insulin stability was much better than that of MIC SD at a 60 degrees C/dry condition. However, moisture lowered the insulin stability and changed the particle morphology of MIC Mix with time at a 60 degrees C/75% relative humidity condition, suggesting that a package preventing moisture absorption was necessary for the MIC Mix powder.


Assuntos
Insulina/administração & dosagem , Insulina/química , Administração por Inalação , Animais , Bacitracina/química , Glicemia/análise , Ácido Cítrico/química , Estabilidade de Medicamentos , Eletroforese em Gel de Poliacrilamida , Hexoses/química , Insulina/farmacocinética , Pulmão/metabolismo , Masculino , Tamanho da Partícula , Pós , Ratos , Ratos Sprague-Dawley , Tecnologia Farmacêutica , Difração de Raios X
12.
Chem Pharm Bull (Tokyo) ; 52(4): 444-6, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15056961

RESUMO

The influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier was investigated. In the present study, drug/carrier powder mixtures were prepared consisting of micronized salbutamol sulfate and lactose carriers with different particle surface conditions prepared by surface covering. Lactose carrier surfaces were covered with vegetable magnesium stearate (Mg-St-V) by a high-speed elliptical-rotor-type powder mixer (Theta-Composer). These powder mixtures were aerosolized by a Jethaler), and the in vitro inhalation properties of salbutamol sulfate were evaluated by a twin impinger. Compared with the powder mixed with uncovered lactose carrier, the in vitro inhalation properties of the powder mixture prepared using the surface covered lactose carrier were little decreased with increased in relative humidity (RH), showing that the in vitro inhalation properties of salbutamol sulfate were improved at high RH. Using this surface covering technique would thus be valuable for storage humidity of dry powder inhalation (DPI) with lactose carrier particles.


Assuntos
Albuterol/administração & dosagem , Albuterol/química , Broncodilatadores/administração & dosagem , Broncodilatadores/química , Administração por Inalação , Química Farmacêutica , Portadores de Fármacos , Armazenamento de Medicamentos , Umidade , Lactose , Magnésio/química , Microscopia Eletrônica de Varredura , Pós , Propriedades de Superfície
13.
Chem Pharm Bull (Tokyo) ; 52(3): 350-3, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14993760

RESUMO

The effect of the surface layering time of lactose carrier particles on the dry powder inhalation properties of salbutamol sulfate was investigated. Lactose carrier particles were layered with vegetable magnesium stearate by physical mixing. In the present study, drug/carrier powder mixtures were designed consisting of micronized salbutamol sulfate and lactose carriers with various particle surface conditions prepared by surface layering. These powder mixtures were aerosolized by a Jethaler, and the in vitro deposition properties of salbutamol sulfate were evaluated by a twin impinger. Compared with the powder mixed with unlayered lactose carrier, the in vitro inhalation properties of the powder mixture prepared using the surface layering lactose carrier were significantly different, showing that the in vitro inhalation properties of the drug/carrier powder mixtures were improved. In vitro deposition properties (RP) increased with surface layering time. Using this surface layering system would thus be valuable for increasing the inhalation properties of dry powder inhalation.


Assuntos
Albuterol/química , Lactose/química , Administração por Inalação , Albuterol/administração & dosagem , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Lactose/administração & dosagem , Microscopia Eletrônica de Varredura , Pós , Propriedades de Superfície
14.
Chem Pharm Bull (Tokyo) ; 51(12): 1455-7, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14646332

RESUMO

The effect of the surface covering of lactose carrier particles on the dry powder inhalation properties of salbutamol sulfate was investigated. Lactose carrier surfaces were covered with sucrose tristearate (J-1803F) by a high-speed elliptical-rotor-type powder mixer (Theta-Composer). In the present study, drug/carrier powder mixtures were prepared consisting of micronized salbutamol sulfate and lactose carriers with various particle surface conditions prepared by surface covering. These powder mixtures were aerosolized by a Jethaler), and the in vitro inhalation properties of salbutamol sulfate were evaluated by a twin impinger. Compared with the powder mixed with uncovered lactose carrier, the in vitro inhalation properties of the powder mixture prepared using the surface covering lactose carrier were significantly different, showing that the in vitro inhalation properties of salbutamol sulfate were improved. In vitro inhalation properties increased with the percentage of J-1803F added. Using this surface covering system would thus be valuable for increasing the inhalation properties of dry powder inhalation with lactose carrier particles.


Assuntos
Albuterol/química , Lactose/química , Administração por Inalação , Albuterol/administração & dosagem , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Lactose/administração & dosagem , Pós , Propriedades de Superfície
15.
J Pharm Sci ; 92(12): 2475-86, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14603493

RESUMO

The purpose of this study was to improve insulin absorption from dry powder after administration in lung without an absorption enhancer. The dry powders, with mannitol as a carrier, were prepared with or without an absorption enhancer (citric acid) by supercritical carbon dioxide (SCF) and spray drying (SD) processes. Insulin powder was precipitated from dimethyl sulfoxide and aqueous solutions by dispersing the insulin solutions from parallel and V-type nozzles, respectively, into supercritical carbon dioxide, which is an antisolvent for insulin. In vitro aerosol performance was evaluated with a cascade impactor. Insulin powder containing citric acid prepared by the SCF method (MIC SCF) showed improved inhalation performance compared with insulin powder prepared by the SD process, although the particle size of the former powder was larger than that in powders prepared by SD. Insulin absorption was estimated from the change in plasma glucose level. The blood glucose level after administration of the insulin powder without citric acid prepared by the SCF process (MI SCF) decreased rapidly, and a significant difference was observed for areas under the curve of change in plasma glucose concentration versus time (AUCs) between MI SCF and the insulin powder without citric acid prepared by the SD process (MI SD). These results suggest that the SCF technique would be useful to prepare dry powders suitable for inhalation.


Assuntos
Cromatografia com Fluido Supercrítico/métodos , Insulina/administração & dosagem , Insulina/síntese química , Absorção/efeitos dos fármacos , Animais , Área Sob a Curva , Dióxido de Carbono , Bovinos , Cromatografia com Fluido Supercrítico/instrumentação , Injeções Espinhais , Insulina/farmacocinética , Masculino , Pós , Ratos , Ratos Sprague-Dawley
16.
J Pharm Sci ; 92(2): 371-80, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12532386

RESUMO

Chitosan-plasmid DNA (pDNA) complex powders as a pulmonary gene delivery system were prepared with a supercritical carbon dioxide (CO(2)) process and their in vivo activity was evaluated. The powders with mannitol as a carrier were prepared by dispersing aqueous solutions of a luciferase expression plasmid driven by the cytomegalovirus promoter (pCMV-Luc) with or without chitosan as a cationic vector in a supercritical CO(2)/ethanol admixture. The supercritical CO(2) process with a V-shaped nozzle successfully produced chitosan-pDNA powders. The addition of chitosan suppressed the degradation of pCMV-Luc during the supercritical CO(2) process and increased the yield of powders. The luciferase activity in mouse lung was evaluated after pulmonary administration of the powders or pCMV-Luc solutions. The chitosan-pDNA powders increased the luciferase activity in mouse lung compared with pCMV-Luc powders without chitosan or pCMV-Luc solutions with or without chitosan. The chitosan-pDNA powder with an N/P ratio = 5 increased the luciferase activity to 2700% of that of the pCMV-Luc solution. These results suggest that gene powder with chitosan is a useful pulmonary gene delivery system.


Assuntos
Dióxido de Carbono/química , Quitina/análogos & derivados , Quitina/química , DNA/administração & dosagem , DNA/genética , Técnicas de Transferência de Genes , Pulmão/fisiologia , Plasmídeos/genética , Animais , Quitosana , Citomegalovirus/genética , Sistemas de Liberação de Medicamentos , Eletroforese em Gel de Poliacrilamida , Excipientes , Feminino , Vetores Genéticos , Luciferases/genética , Camundongos , Camundongos Endogâmicos ICR , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Pós , Regiões Promotoras Genéticas/genética , Transfecção
17.
Chem Pharm Bull (Tokyo) ; 51(1): 1-5, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12520118

RESUMO

An attempt was made to produce carrier particles for dry powder inhalations by the surface treatment of lactose particles with aqueous ethanol solution. Drug/carrier powder mixtures were prepared consisting of lactose carriers with different particle surface properties and micronized salbutamol sulfate. These powder mixtures were aerosolized by Spinhaler, and in vitro deposition properties of salbutamol sulfate were evaluated by twin impinger. The degree of adhesion between drug particles and carrier particles was determined by the ultracentrifuge separation method. In addition, the air jet sieve method was used to evaluate characteristics of the separation of drug particles from carrier particles in airflow. The average adhesion force (F50) between the surface-treated lactose carrier and drug particles was significantly lower than that of powder mixed with the untreated lactose carrier, indicating that the degree of separation (T50) of drug particles from carrier particles was improved when surface-treated lactose carrier was used. This resulted in an improvement of in vitro inhalation properties.


Assuntos
Lactose/síntese química , Tecnologia Farmacêutica/métodos , Portadores de Fármacos/síntese química , Pós , Propriedades de Superfície
18.
J Pharm Sci ; 91(11): 2424-32, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12379928

RESUMO

In previous studies, we prepared film dosage forms of lidocaine (LC) with hydroxypropylcellulose (HPC) as a film base using the solvent evaporation (SE) method. However, from the viewpoint of environmental issues, a reduction in organic solvent use in pharmaceutical and other industries is required. In this study, we prepared the LC films by direct compression of the physical mixture (DCPM method) and direct compression of the spray dried powder (DCSD method). Magnesium stearate, which was required as a lubricant for direct compression, showed no effect on the LC release rate. The LC release rate (%/h) was independent of the compression pressure, but a higher pressure was preferable to easily remove the film from the punches. An increase in the film weight decreased the LC release rate expressed in %/h, whereas no significant effect of film weight was observed on the LC release rate from unit surface area expressed in mg/h/cm(2). The LC release rate (%/h) was independent of the LC content, suggesting that the LC release rate (mg/h) can be quantitatively controlled by changing the LC content in the formulation. The LC release rate and penetration rate were affected by the preparation method; that is, DCPM method < DCSD method < SE method. The LC penetration rates through excised hamster oral mucosa were linearly correlated to the release rate of un-ionized LC, which was estimated by the LC release rate multiplied by the un-ionized fraction of LC for the HPC film dosage form.


Assuntos
Lidocaína/administração & dosagem , Lidocaína/síntese química , Polímeros/administração & dosagem , Polímeros/síntese química , Tecnologia Farmacêutica/métodos , Administração Bucal , Animais , Cricetinae , Formas de Dosagem , Técnicas In Vitro , Lidocaína/farmacocinética , Masculino , Mesocricetus , Polímeros/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...